In August 2025, Assort Health raised $50 million in Series B funding, at a valuation of $750 million, just four months after its Series A, signaling investor confidence in its rapid adoption and business model. Earlier in April 2025, it raised $26 million in institutional financing, citing 8ร— revenue growth since Q4 2024, broad adoption across specialties, and operational results like cutting hold times from ~11 minutes to under a minute in pilot clinics.